Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON.
| Revenue (Most Recent Fiscal Year) | $4.79B |
| Net Income (Most Recent Fiscal Year) | $-317.00M |
| PE Ratio (Current Year Earnings Estimate) | 24.65 |
| PE Ratio (Trailing 12 Months) | 24.38 |
| PEG Ratio (Long Term Growth Estimate) | 1.32 |
| Price to Sales Ratio (Trailing 12 Months) | 0.86 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.64 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 6.25 |
| Pre-Tax Margin (Trailing 12 Months) | -6.71% |
| Net Margin (Trailing 12 Months) | -7.50% |
| Return on Equity (Trailing 12 Months) | 2.62% |
| Return on Assets (Trailing 12 Months) | 1.28% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.56 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.96 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.74 |
| Inventory Turnover (Trailing 12 Months) | 1.81 |
| Book Value per Share (Most Recent Fiscal Quarter) | $18.57 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.07 |
| Earnings per Share (Most Recent Fiscal Year) | $0.58 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.03 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 353.72M |
| Free Float | 353.19M |
| Market Capitalization | $4.14B |
| Average Volume (Last 20 Days) | 0.64M |
| Beta (Past 60 Months) | 0.56 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.15% |
| Percentage Held By Institutions (Latest 13F Reports) | 11.07% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |